Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fioretti

Showing results (81-90 of 192) with videos related to

Pageof 20
Sort By:
The Journal of Clinical Endocrinology and Metabolism|May 1, 1988
Restoration of luteinizing hormone response to naloxone in postmenopausal women by chronic administration of the antidopaminergic drug veraliprideG B Melis, A Cagnacci, M Gambacciani, et al.
European Journal of Gynaecological Oncology|January 1, 1990
A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinomaA Gadducci, M Ferdeghini, C Prontera, et al.
European Journal of Gynaecological Oncology|January 1, 1986
Combined evaluation of some tumor associated antigens in the monitoring of integrated surgical and chemotherapeutic treatment of epithelial ovarian cancerP Fioretti, A Gadducci, M Ferdeghini, et al.
The Journal of Nuclear Medicine and Allied Sciences|January 1, 1989
The serum concentrations of TAG-72 antigen measured with CA 72-4 IRMA in patients with ovarian carcinoma. Preliminary dataA Gadducci, M Ferdeghini, T Ceccarini, et al.
Neuroendocrinology|February 1, 1988
Chronic bromocriptine administration restores luteinizing hormone response to naloxone in postmenopausal womenG B Melis, A Cagnacci, M Gambacciani, et al.
Journal of Medical Genetics|October 1, 1979
Prenatal diagnosis of beta-thalassaemia by fetal red cell concentration with anti-AB serumM Furbetta, C Valenti, A Ximenes, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|January 1, 1991
CA 195: a new monoclonal antibody-defined Lea blood group-related tumor marker in patients with epithelial ovarian cancerA Gadducci, M Ferdeghini, C Prontera, et al.
European Journal of Gynaecological Oncology|January 1, 1988
The association of ultrasonography and CA-125 test in the preoperative evaluation of ovarian carcinomaA Gadducci, P Capriello, T Bartolini, et al.
Epilepsy Research|March 1, 1989
Unbalanced progesterone and estradiol secretion in catamenial epilepsyU Bonuccelli, G B Melis, A M Paoletti, et al.
Fertility and Sterility|September 1, 1989
Reduction in the size of prolactin-producing pituitary tumor after Cabergoline administrationG B Melis, M Gambacciani, A M Paoletti, et al.
Pageof 20

Showing results (81-90 of 192) with videos related to

Sort By:
Pageof 20
The Journal of Clinical Endocrinology and Metabolism|May 1, 1988
Restoration of luteinizing hormone response to naloxone in postmenopausal women by chronic administration of the antidopaminergic drug veraliprideG B Melis, A Cagnacci, M Gambacciani, et al.
European Journal of Gynaecological Oncology|January 1, 1990
A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinomaA Gadducci, M Ferdeghini, C Prontera, et al.
European Journal of Gynaecological Oncology|January 1, 1986
Combined evaluation of some tumor associated antigens in the monitoring of integrated surgical and chemotherapeutic treatment of epithelial ovarian cancerP Fioretti, A Gadducci, M Ferdeghini, et al.
The Journal of Nuclear Medicine and Allied Sciences|January 1, 1989
The serum concentrations of TAG-72 antigen measured with CA 72-4 IRMA in patients with ovarian carcinoma. Preliminary dataA Gadducci, M Ferdeghini, T Ceccarini, et al.
Neuroendocrinology|February 1, 1988
Chronic bromocriptine administration restores luteinizing hormone response to naloxone in postmenopausal womenG B Melis, A Cagnacci, M Gambacciani, et al.
Journal of Medical Genetics|October 1, 1979
Prenatal diagnosis of beta-thalassaemia by fetal red cell concentration with anti-AB serumM Furbetta, C Valenti, A Ximenes, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|January 1, 1991
CA 195: a new monoclonal antibody-defined Lea blood group-related tumor marker in patients with epithelial ovarian cancerA Gadducci, M Ferdeghini, C Prontera, et al.
European Journal of Gynaecological Oncology|January 1, 1988
The association of ultrasonography and CA-125 test in the preoperative evaluation of ovarian carcinomaA Gadducci, P Capriello, T Bartolini, et al.
Epilepsy Research|March 1, 1989
Unbalanced progesterone and estradiol secretion in catamenial epilepsyU Bonuccelli, G B Melis, A M Paoletti, et al.
Fertility and Sterility|September 1, 1989
Reduction in the size of prolactin-producing pituitary tumor after Cabergoline administrationG B Melis, M Gambacciani, A M Paoletti, et al.
Pageof 20